AHCO Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -10.03%, SMA50 -10.96%, SMA200 -4.14%). The stock’s 14-day RSI is 36.77 (weak momentum), while the ATR of 0.5 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -21.93% below its high and over 27.8% above its low. Average 10-day trading volume of 4.39 million shares is significantly above the 3-month average of 1.83 million, indicating heightened recent market interest.

AdaptHealth Corp. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $23.01. This means the shares are trading below this model’s fair value.

AdaptHealth Corp. generated EPS of -$0.53 over the past year. Five-year average earnings growth is 29.83%. Wall Street analysts project EPS growth of 29.34% annually over the next five years. The latest quarter delivered EPS of $0.06. The next quarter is forecast at $0.01. Next year's EPS is expected at -$3.59. Analyst sentiment is bullish. Analyst rating data shows there are 3 Strong Buy ratings, 5 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $16.00 to $13.00. The high target offers 146.15% upside. The low target suggests 100.0% downside. The mean target is $14.38. This offers 121.23% upside. AdaptHealth Corp. earnings surprise history is frequent misses against expectations. The quarter that ended August 04, 2026, missed forecasts by -64.45%. The prior quarter beat by -580.0%. Over the last six quarters, Apple has recorded several small beats. These include 0.0% in May 06, 2025.

AdaptHealth Corp. has 136.05 million shares outstanding. The public float is 85.56 million shares, elevated short interest at 7.79% of float. This equals 8.01 million shares. The short ratio is 4.96 days. Institutional investors hold 116.14% of the float. Insiders own 8.14%. OEP VII GP, L.L.C. holds 16.31 million shares, CASHIN RICHARD M JR has 16.31 million shares and Everest Hill Group Inc. has 12.81 million shares. Over the past six months, insider transactions show net buying. They sold 22.55 thousand shares across 2 transactions.

AdaptHealth Corp. (NASDAQ:AHCO) closed at $6.50 USD, losing -$0.21 (-3.20%) from the previous close of $6.71. The stock is currently within 5% of its 52-week low $6.34 and $13.43. With a market capitalization of about $883.67 million, AdaptHealth Corp. is classified as a small-cap and shows higher-than-market volatility (beta ~1.45). Key stats such as the average daily volume over the past year has been around 1.36 million shares, trading with heavier-than-usual volume. Headquartered in Conshohocken, PA, AdaptHealth Corp. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Suzanne Foster, the company employs approximately 10,900 people and listed since May 31, 2018. AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States.

AdaptHealth Corp. trades at a P/E ratio of -3.87, slightly below the S&P 500 average, with a price-to-sales ratio of 0.29 and a price-to-book ratio of 0.64 suggesting the stock is closer to book value. The P/FCF stands at 9.06, also above market averages.

Our AI price prediction model suggests that AdaptHealth Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 37.23%, with price expected at $8.92 by August 18, 2026, within a range of $8.29 to $9.59 3-Month Outlook: Projected rise of 22.92%, reaching $7.99 by November 02, 2026, with a range of $7.46 to $8.53. 1-Year Outlook: Projected gain of 240.0%, with price at $22.10 by August 04, 2027, within a range of $14.69 to $30.45.

AdaptHealth Corp. (NASDAQ:AHCO) shares are flat 4.42% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows AdaptHealth Corp. trading at a premium to the broader market with a P/E of -3.87. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $18.89, suggesting 190.62% upside. Our AI forecast model points to short-term strength (37.23% over two weeks), a medium-term rise (22.92% over three months), and a longer-term gain (240.0% over one year), with expected trading ranges indicating moderate volatility.